The Fig portfolio companies
Innoture develops and manufactures microneedles and microneedle patches for use in drug delivery, diagnostics and monitoring. The technology allows for pain-free and highly efficient transdermal substrate delivery.
Innoture’s microneedle platform is an extremely flexible, simple and cost effective solution applicable to many transdermal scenarios.
Its IP allows freedom to operate within the crowded microneedle landscape and offers a truly adaptative, tailored, application optimised solution.
Research and development is based at the state-of-the-art institute of Life Science Swansea University and there is a knowledge transfer partnership in place with the Biocomposites Centre at Bangor University. The company is backed by a range of notable investors from the pharmaceutical industry.